SCHEMBL623258

SCHEMBL623258

CCOC(=O)N1Cc2sc(C(=O)OC)c(NC(N)=O)c2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.43
KDM4E B2RXH2 3/20 0.43
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 8/20 0.42
PKM P14618 1/20 0.42
BLM P54132 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 6/20 0.40
HPGD P15428 5/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
TSHR P16473 2/20 0.40
ALOX15 P16050 2/20 0.40
HTT P42858 2/20 0.40
UBE2N P61088 1/20 0.40
KMT2A Q03164 4/20 0.39
TP53 P04637 3/20 0.39
MEN1 O00255 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL624101 0.90 MAPT (0.46) MAPTKDM4EGAANPSR1PKM
SCHEMBL623301 0.83 MAPT (0.49) MAPTKDM4EGAANPSR1PKM
SCHEMBL14261377 0.73 ALDH1A1 (0.54) MAPTKDM4EGAANPSR1ALDH1A1
SCHEMBL623383 0.72 MAPT (0.52) MAPTKDM4EGAANPSR1PKM
SCHEMBL937821 0.69 ADORA1 (0.65) MAPTKDM4EGAAL3MBTL1TDP1
SCHEMBL16007549 0.68 ADORA1 (0.72) MAPTKDM4EGAANPSR1PKM
SCHEMBL624102 0.67 ADORA1 (0.49) MAPTKDM4EGAAATMALDH1A1
SCHEMBL16020430 0.65 NPSR1 (0.55) MAPTKDM4EGAANPSR1PKM
SCHEMBL16017714 0.64 ADORA1 (0.57) MAPTKDM4EGAANPSR1PKM
SCHEMBL624426 0.63 MAPT (0.41) MAPTKDM4EGAAATMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012020227-A1 TRICYCLIC COMPOUNDS FOR USE AS KINASE INHIBITORS CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) 2012-02-16 WO disclosed